("imiquimod" [Supplementary Concept] AND "Aminoquinolines/therapeutic use"[Mesh])
(Imiquimod OR Imikimod OR Imikimodi OR Imiquimodum OR R-837 OR S-26308 OR Aldara OR Beselna OR Imimor OR Imimore OR Labimiq OR Miquimod OR Quinilan OR Tocasol OR Virosupril OR Zyclara)
Saturday, May 14, 2011
Vandetanib (therapeutic use) -- MeSH and keyword
"N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine" [Supplementary Concept] AND ("Piperidines/therapeutic use"[Mesh] OR "Quinazolines/therapeutic use"[Mesh])
(Vandetanib* OR Vandetanibum OR AZD6474 OR ZD-6474 OR "ZD 6474" OR ZD6474)
The following muti-word and hyphenated terms were not recognized by PubMed and were removed from the search statement to avoid retrieval of irrelevant results:
AZD-6474 OR "AZD 6474"
(Vandetanib* OR Vandetanibum OR AZD6474 OR ZD-6474 OR "ZD 6474" OR ZD6474)
The following muti-word and hyphenated terms were not recognized by PubMed and were removed from the search statement to avoid retrieval of irrelevant results:
AZD-6474 OR "AZD 6474"
gadobutrol (diagnostic use) -- MeSH and keywords
"gadobutrol" [Supplementary Concept] AND "Organometallic Compounds/diagnostic use"[Mesh]
(Gadobutrol OR Gadobutrolum OR ZK135079 OR Gadograf OR Gadovist )
The following hyphenated and multi-word terms have been removed from the search
ZK-135079 OR "ZK 135079"
(Gadobutrol OR Gadobutrolum OR ZK135079 OR Gadograf OR Gadovist )
The following hyphenated and multi-word terms have been removed from the search
ZK-135079 OR "ZK 135079"
Roflumilast (therapeutic use) -- MeSH and keywords
"Roflumilast" [Supplementary Concept] AND ("Aminopyridines/therapeutic use"[Mesh] OR "Benzamides/therapeutic use"[Mesh] OR "Cyclopropanes/therapeutic use"[Mesh])
(Roflumilast* OR Roflumilastum OR APTA2217 OR B9302-107 OR BY217 OR BYK20869 OR Daxas OR Daliresp)
The following hyphenated and multiword phrases were not recognized, caused retrieval of irrelevant results and so were removed from the search statement.
APTA-2217 OR "APTA 2217" OR B-9302-107 OR "B 9302-107" OR BY-217 OR "BY 217" OR BYK-20869 OR "BYK 20869"
(Roflumilast* OR Roflumilastum OR APTA2217 OR B9302-107 OR BY217 OR BYK20869 OR Daxas OR Daliresp)
The following hyphenated and multiword phrases were not recognized, caused retrieval of irrelevant results and so were removed from the search statement.
APTA-2217 OR "APTA 2217" OR B-9302-107 OR "B 9302-107" OR BY-217 OR "BY 217" OR BYK-20869 OR "BYK 20869"
azilsartan (therapeutic use) -- MeSH and keywords
"azilsartan medoxomil" [Supplementary Concept] AND ("Benzimidazoles/therapeutic use"[Mesh] OR "Oxadiazoles/therapeutic use"[Mesh])
(Azilsartan* OR Azilsartan OR Azilsartanum OR TAK-491 OR "TAK-491" OR TAK491 OR edarbi)
(Azilsartan* OR Azilsartan OR Azilsartanum OR TAK-491 OR "TAK-491" OR TAK491 OR edarbi)
vilazodone (therapeutic use) -- MeSH and keywords
"vilazodone" [Supplementary Concept] AND ("Benzofurans/therapeutic use"[Mesh] OR "Indoles/therapeutic use"[Mesh] OR "Piperazines/therapeutic use"[Mesh])
( vilazodon* OR Vilazodone OR vilazodona OR Vilazodoni OR Viibryd OR vilazodonum OR EMD-68843 OR "EMD 68843" OR EMD68843 OR SB659746A OR EMD515259)
The following terms are not recognized by PubMed, were causing retrieval of irrelevant results and have been removed from the search statement:
SB-659746A OR "SB 659746A" OR EMD-515259 OR "EMD 515259"
( vilazodon* OR Vilazodone OR vilazodona OR Vilazodoni OR Viibryd OR vilazodonum OR EMD-68843 OR "EMD 68843" OR EMD68843 OR SB659746A OR EMD515259)
The following terms are not recognized by PubMed, were causing retrieval of irrelevant results and have been removed from the search statement:
SB-659746A OR "SB 659746A" OR EMD-515259 OR "EMD 515259"
aliskiren (therapeutic use) -- MeSH and keywords
("aliskiren" [Supplementary Concept] AND ("Amides/therapeutic use"[Mesh] OR "Fumarates/therapeutic use"[Mesh]))
(aliskiren* OR aliskirene OR aliskireni OR aliskireno OR CGP-60536B OR "CGP 60536B" OR CGP60536B OR SPP-100 OR "SPP 100" OR SPP100 OR Enviage OR Rasilez OR Rasilles OR Riprazo OR Sprimeo OR Tekamlo OR Tekturna)
(aliskiren* OR aliskirene OR aliskireni OR aliskireno OR CGP-60536B OR "CGP 60536B" OR CGP60536B OR SPP-100 OR "SPP 100" OR SPP100 OR Enviage OR Rasilez OR Rasilles OR Riprazo OR Sprimeo OR Tekamlo OR Tekturna)
Subscribe to:
Posts (Atom)